Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 7:02 AM ET

Healthcare Providers and Services

Company Overview of WellDyneRx, Inc.

Company Overview

WellDyneRx, Inc., a pharmacy benefit management company, provides health improvement services. It offers a range of services, including an integrated pharmacy network, formulary review, customized reporting, online enrollment, and online access to health, disease, and drug information. The company serves its health plan members through a retail network of pharmacies in the United States. WellDyneRx, Inc. was formerly known as RxWEST, Inc. The company was founded in 1990 and is based in Centennial, Colorado. WellDyneRx, Inc. operates as a subsidiary of WellDyne, Inc.

7472 South Tucson Way

Centennial, CO 80112

United States

Founded in 1990

Phone:

303-793-9954

Fax:

303-793-0925

Key Executives for WellDyneRx, Inc.

Chief Executive Officer and President
Chief Operating Officer
Vice President of Account Development
Chief Information Officer
Vice President of Operations Support
Compensation as of Fiscal Year 2015.

WellDyneRx, Inc. Key Developments

WellDyneRx Selects Elsevier's Predictive Acquisition Cost (PAC) Drug Price Solution

Elsevier announced an agreement with WellDyneRx to use Elsevier's Predictive Acquisition Cost (PAC). PAC, offered exclusively by Elsevier, is a drug price solution that closely tracks true acquisition cost. WellDyneRx services approximately six million health plan members through a retail network of over 65,000 pharmacies nationwide. WellDyneRx, based in Lakeland, FL, will use PAC to optimize its maximum allowable cost (MAC) list and identify opportunities for client savings. With a better balanced MAC list, WellDyneRx will be able to stay current with pricing in the volatile generic market and comply with state MAC transparency regulations. PAC, developed by Glass Box Analytics and exclusively published by Elsevier, is a new drug price solution that closely tracks true acquisition cost by leveraging proven concepts from other industries and applying the power of predictive analytics to drug pricing. Independent tests show that PAC comes closer to true acquisition cost than alternatives.

Similar Private Companies By Industry

Company Name Region
@home approach, llc United States
Companion Global Healthcare, Inc. United States
HLG Health Communications United States
HealthForce Partners, LLC United States
The Sexual Health Network, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WellDyneRx, Inc., please visit www.welldynerx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.